6855 fundamentals
Key facts
Market capitalization—
Founded—
CEO—
Website—
About
Ascentage Pharma Group International Co., Ltd. is a clinical-stage biotechnology company, which engages in the development of novel therapies for cancers, hepatitis B virus, or HBV, and age-related diseases. It operates through United States and Mainland China geographical segments. The company was founded by Dajun Yang and Ming Guo in May 2009 and is headquartered in Suzhou, China.
Valuation
Fundamental metrics to determine fair value of the stock
Growth and Profitability
Company’s recent performance and margins
Dividends
Dividend yield, history and sustainability
6855 does not pay dividends
The company has not previously paid dividends and at the moment there is no information about whether it is going to pay them in the future
Financial health
Financial position and solvency of the company